位置：成果数据库 > 期刊 > 期刊详情页
Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in huma
  • ISSN号：1872-6240 (Electronic)0006-8993 (Linking)
  • 期刊名称：Brain Res
  • 时间：0
  • 页码：27-37
  • 语言：英文
  • 相关项目：解析GBM基于EGFR/PI3K信号通路多模式靶向治疗靶标的研究
作者： Lan Fengming|Yang Weidong|Jiang Tao|Zhang Anling|Yue Xiao|Yang Yang|Liu Jilong|Zeng Huazong|Han Lei|
同期刊论文项目
解析GBM基于EGFR/PI3K信号通路多模式靶向治疗靶标的研究
期刊论文 13 会议论文 3 著作 1
同项目期刊论文
Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features.
Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-media
Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents
Prognostic factors influencing clinical outcomes of glioblastoma multiforme
Selective inhibition on PDGFR by imatinib elicits sustained activation of ERK and downstream recepto
抗血管生成靶向药物治疗恶性胶质瘤的临床研究
siRNA靶向抑制PDGFRB对人恶性脑胶质瘤细胞增殖的抑制作用
以表皮生长因子受体为靶点恶性脑胶质瘤靶向治疗研究进展
脑胶质瘤循环标志物